Shadaba Asad1, Joseph Sweeney, Leonard A Mermel. 1. Division of Infectious Diseases, Department of Medicine, and Transfusion Medicine, Rhode Island Hospital, Providence, RI 02903, USA.
Abstract
BACKGROUND: Babesiosis is caused by an intraerythrocytic protozoan transmitted by ticks. Blood transfusion is another mode of transmission. STUDY DESIGN AND METHODS: This was a retrospective study based on babesiosis cases reported to the Rhode Island Department of Health between 1999 and 2007. Additional cases were also identified. RESULTS: Twenty-one cases of transfusion-transmitted babesiosis (TTB) were identified from 1999 through 2007. From 2005 through 2007, the incidence approached one case per 9000 units of blood transfused. One of 21 (5%) TTB cases was diagnosed in July, in sharp contrast to 65 of 152 (43%) of the total babesiosis cases diagnosed during July in Rhode Island. Many cases were identified when a complete blood count with a differential was routinely requested and parasites were noted by laboratory technologists. Most patients with TTB had underlying conditions known to predispose to symptomatic infection. CONCLUSION: Blood transfusion is an important mode of Babesia transmission. The current screening method of omitting donors with a history of babesiosis may be effective in preventing some, but not all, cases of TTB and current processing of blood products does not eradicate this parasite. Thus, a better screening test is needed. Alternatively, pathogen reduction technology could be utilized to prevent this mode of transmission.
BACKGROUND:Babesiosis is caused by an intraerythrocytic protozoan transmitted by ticks. Blood transfusion is another mode of transmission. STUDY DESIGN AND METHODS: This was a retrospective study based on babesiosis cases reported to the Rhode Island Department of Health between 1999 and 2007. Additional cases were also identified. RESULTS: Twenty-one cases of transfusion-transmitted babesiosis (TTB) were identified from 1999 through 2007. From 2005 through 2007, the incidence approached one case per 9000 units of blood transfused. One of 21 (5%) TTB cases was diagnosed in July, in sharp contrast to 65 of 152 (43%) of the total babesiosis cases diagnosed during July in Rhode Island. Many cases were identified when a complete blood count with a differential was routinely requested and parasites were noted by laboratory technologists. Most patients with TTB had underlying conditions known to predispose to symptomatic infection. CONCLUSION: Blood transfusion is an important mode of Babesia transmission. The current screening method of omitting donors with a history of babesiosis may be effective in preventing some, but not all, cases of TTB and current processing of blood products does not eradicate this parasite. Thus, a better screening test is needed. Alternatively, pathogen reduction technology could be utilized to prevent this mode of transmission.
Authors: Mark W Eshoo; Chris D Crowder; Heather E Carolan; Megan A Rounds; David J Ecker; Heike Haag; Benedikt Mothes; Oliver Nolte Journal: Vector Borne Zoonotic Dis Date: 2014-08 Impact factor: 2.133
Authors: David A Leiby; Stephanie T Johnson; Kimberly Y Won; Eva K Nace; Susan B Slemenda; Norman J Pieniazek; Ritchard G Cable; Barbara L Herwaldt Journal: Transfusion Date: 2014-03-28 Impact factor: 3.157
Authors: Jeffrey W Priest; Delynn M Moss; Kimberly Won; Charles W Todd; Leslie Henderson; Cara C Jones; Marianna Wilson Journal: Clin Vaccine Immunol Date: 2012-08-01
Authors: Mikhail Menis; Richard A Forshee; Sanjai Kumar; Stephen McKean; Rob Warnock; Hector S Izurieta; Rahul Gondalia; Chris Johnson; Paul D Mintz; Mark O Walderhaug; Christopher M Worrall; Jeffrey A Kelman; Steven A Anderson Journal: PLoS One Date: 2015-10-15 Impact factor: 3.240
Authors: Meghan B Brennan; Barbara L Herwaldt; James J Kazmierczak; John W Weiss; Christina L Klein; Catherine P Leith; Rong He; Matthew J Oberley; Laura Tonnetti; Patricia P Wilkins; Gregory M Gauthier Journal: Emerg Infect Dis Date: 2016-11 Impact factor: 6.883